• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辉瑞-生物科技公司2019年冠状病毒病mRNA疫苗接种后横纹肌溶解症反复出现的肌无力

Recurring Weakness in Rhabdomyolysis Following Pfizer-BioNTech Coronavirus Disease 2019 mRNA Vaccination.

作者信息

Kimura Motoya, Niwa Jun-Ichi, Doyu Manabu

机构信息

Department of Neurology, Aichi Medical University, 1-1 Yazakokarimata, Nagakute 480-1195, Japan.

出版信息

Vaccines (Basel). 2022 Jun 11;10(6):935. doi: 10.3390/vaccines10060935.

DOI:10.3390/vaccines10060935
PMID:35746543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9230860/
Abstract

Rhabdomyolysis is a well-known clinical syndrome of muscle injury. Rhabdomyolysis following coronavirus disease 2019 (COVID-19) vaccination has recently been reported. The patients' weakness gradually subsided and did not recur. Rhabdomyolysis associated with COVID-19 vaccination has not been assessed by repeated magnetic resonance imaging (MRI) within a short time. We report a rare case of an older woman who developed recurring weakness with rhabdomyolysis after COVID-19 vaccination. A 76-year-old woman presented with myalgia 2 days after receiving a third dose of the COVID-19 vaccine. A physical examination showed weakness of the bilateral iliopsoas muscles. Her creatine kinase concentration was 9816 U/L. MRI showed hyperintensity of multiple limb muscles. She was treated with intravenous normal saline. Her symptoms disappeared within 3 days. However, MRI on day 4 of hospitalization showed exacerbation of the hyperintensity in the left upper limb muscles. On day 5 of hospitalization, weakness of the left supraspinatus and deltoid muscles appeared. MRI on day 8 of hospitalization showed attenuation of the hyperintensity in all muscles. Her weakness and elevated creatine kinase concentration disappeared by day 10. Repeated MRI over a short time may be useful to predict potential weakness and monitor the course of COVID-19 vaccine-induced rhabdomyolysis.

摘要

横纹肌溶解症是一种众所周知的肌肉损伤临床综合征。最近有报告称2019冠状病毒病(COVID-19)疫苗接种后出现横纹肌溶解症。患者的肌无力逐渐消退且未复发。与COVID-19疫苗接种相关的横纹肌溶解症尚未在短时间内通过重复磁共振成像(MRI)进行评估。我们报告了一例罕见病例,一名老年女性在接种COVID-19疫苗后出现复发性肌无力并伴有横纹肌溶解症。一名76岁女性在接种第三剂COVID-19疫苗后2天出现肌痛。体格检查显示双侧髂腰肌无力。她的肌酸激酶浓度为9816 U/L。MRI显示多块肢体肌肉呈高信号。她接受了静脉输注生理盐水治疗。她的症状在3天内消失。然而,住院第4天的MRI显示左上肢肌肉高信号加重。住院第5天,出现左冈上肌和三角肌无力。住院第8天的MRI显示所有肌肉的高信号减弱。到第10天,她的肌无力和肌酸激酶浓度升高消失。短时间内重复进行MRI可能有助于预测潜在的肌无力并监测COVID-19疫苗诱导的横纹肌溶解症病程。

相似文献

1
Recurring Weakness in Rhabdomyolysis Following Pfizer-BioNTech Coronavirus Disease 2019 mRNA Vaccination.辉瑞-生物科技公司2019年冠状病毒病mRNA疫苗接种后横纹肌溶解症反复出现的肌无力
Vaccines (Basel). 2022 Jun 11;10(6):935. doi: 10.3390/vaccines10060935.
2
Rhabdomyolysis after COVID-19 Comirnaty Vaccination: A Case Report.新冠病毒mRNA疫苗Comirnaty接种后横纹肌溶解症:一例报告
Case Rep Neurol. 2022 Nov 4;14(3):429-432. doi: 10.1159/000527599. eCollection 2022 Sep-Dec.
3
Severe rhabdomyolysis secondary to COVID-19 mRNA vaccine in a teenager.青少年感染 COVID-19 mRNA 疫苗后出现严重横纹肌溶解症。
Pediatr Nephrol. 2023 Jun;38(6):1979-1983. doi: 10.1007/s00467-022-05808-7. Epub 2022 Nov 21.
4
Rhabdomyolysis Secondary to COVID-19 Vaccination.新冠疫苗接种继发横纹肌溶解症
Cureus. 2021 May 13;13(5):e15004. doi: 10.7759/cureus.15004.
5
Rhabdomyolysis Following Ad26.COV2.S COVID-19 Vaccination.Ad26.COV2.S新冠疫苗接种后发生的横纹肌溶解症
Vaccines (Basel). 2021 Aug 27;9(9):956. doi: 10.3390/vaccines9090956.
6
A Case of Rhabdomyolysis in a Young, Morbidly Obese, Asthmatic Woman With COVID-19.一名患有新冠肺炎的年轻病态肥胖哮喘女性横纹肌溶解症病例。
Cureus. 2022 Sep 8;14(9):e28950. doi: 10.7759/cureus.28950. eCollection 2022 Sep.
7
Severe Rhabdomyolysis in a 35-Year-old Woman with COVID-19 due to SARS-CoV-2 Infection: A Case Report.一名35岁感染新型冠状病毒肺炎(COVID-19)的女性因严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染导致横纹肌溶解症:病例报告
Am J Case Rep. 2020 Aug 17;21:e926733. doi: 10.12659/AJCR.926733.
8
Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination.病例报告:辉瑞-生物科技 COVID-19 mRNA 疫苗接种后出现横纹肌溶解症和寡免疫细胞性新月体性肾小球肾炎的抗中性粒细胞胞质抗体相关性血管炎。
Front Immunol. 2021 Sep 30;12:762006. doi: 10.3389/fimmu.2021.762006. eCollection 2021.
9
Incomplete Subacute Transverse Myelitis Following Vaccination With Pfizer-BioNTech COVID-19 mRNA Vaccine: A Case Report.接种辉瑞-生物科技公司新冠mRNA疫苗后发生的不完全性亚急性横贯性脊髓炎:一例报告
Cureus. 2021 Dec 16;13(12):e20460. doi: 10.7759/cureus.20460. eCollection 2021 Dec.
10
Rhabdomyolysis Following Recovery from Severe COVID-19: A Case Report.重症 COVID-19 康复后发生横纹肌溶解症:一例报告
Am J Case Rep. 2021 May 8;22:e931616. doi: 10.12659/AJCR.931616.

引用本文的文献

1
Assessing the impact of mRNA vaccination in chronic inflammatory murine model.评估mRNA疫苗接种在慢性炎症小鼠模型中的影响。
NPJ Vaccines. 2024 Feb 15;9(1):34. doi: 10.1038/s41541-024-00825-z.
2
A severe case of rhabdomyolysis after Moderna mRNA anti-COVID-19 vaccine with a literature review.1例接种Moderna mRNA新冠疫苗后发生的严重横纹肌溶解症并文献复习
Clin Case Rep. 2023 May 16;11(5):e7184. doi: 10.1002/ccr3.7184. eCollection 2023 May.
3
Clinical and Molecular Characterization of a Rare Case of BNT162b2 mRNA COVID-19 Vaccine-Associated Myositis.

本文引用的文献

1
Fatal thrombotic microangiopathy with rhabdomyolysis as an initial symptom after the first dose of mRNA-1273 vaccine: A case report.mRNA-1273 疫苗接种后首例以横纹肌溶解为首发表现的致命性血栓性微血管病:1 例报告。
Int J Infect Dis. 2022 Apr;117:322-325. doi: 10.1016/j.ijid.2022.02.031. Epub 2022 Feb 18.
2
Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine: A Case Report.心肌炎、肺出血和广泛肌炎伴横纹肌溶解症,在接种第一剂辉瑞-BioNTech BNT162b2 mRNA COVID-19 疫苗 12 天后:病例报告。
Am J Case Rep. 2022 Feb 17;23:e934399. doi: 10.12659/AJCR.934399.
3
BNT162b2 mRNA新冠疫苗相关肌炎罕见病例的临床与分子特征
Vaccines (Basel). 2022 Jul 16;10(7):1135. doi: 10.3390/vaccines10071135.
Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination.
病例报告:辉瑞-生物科技 COVID-19 mRNA 疫苗接种后出现横纹肌溶解症和寡免疫细胞性新月体性肾小球肾炎的抗中性粒细胞胞质抗体相关性血管炎。
Front Immunol. 2021 Sep 30;12:762006. doi: 10.3389/fimmu.2021.762006. eCollection 2021.
4
Rhabdomyolysis Following Ad26.COV2.S COVID-19 Vaccination.Ad26.COV2.S新冠疫苗接种后发生的横纹肌溶解症
Vaccines (Basel). 2021 Aug 27;9(9):956. doi: 10.3390/vaccines9090956.
5
Rhabdomyolysis Following Administration of Comirnaty.接种辉瑞-BioNTech新冠疫苗后发生的横纹肌溶解症。
Eur J Case Rep Intern Med. 2021 Aug 30;8(8):002796. doi: 10.12890/2021_002796. eCollection 2021.
6
COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis.新冠病毒信使核糖核酸疫苗诱发横纹肌溶解症和筋膜炎。
J Neurol. 2022 Apr;269(4):1774-1775. doi: 10.1007/s00415-021-10768-3. Epub 2021 Aug 25.
7
Systems vaccinology of the BNT162b2 mRNA vaccine in humans.人体中 BNT162b2 mRNA 疫苗的系统疫苗学。
Nature. 2021 Aug;596(7872):410-416. doi: 10.1038/s41586-021-03791-x. Epub 2021 Jul 12.
8
COVID-19 vaccine induced rhabdomyolysis: Case report with literature review.新型冠状病毒肺炎疫苗诱导的横纹肌溶解症:病例报告及文献综述
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102170. doi: 10.1016/j.dsx.2021.06.007. Epub 2021 Jun 15.
9
Carnitine palmitoyltransferase II deficiency and post-COVID vaccination rhabdomyolysis.肉碱棕榈酰转移酶 II 缺乏症与新冠疫苗接种后横纹肌溶解症。
QJM. 2021 Nov 5;114(8):596-597. doi: 10.1093/qjmed/hcab077.
10
Combined intravenous immunoglobulin and baricitinib treatment for severe COVID-19 with rhabdomyolysis: A case report.静注人免疫球蛋白和巴瑞替尼联合治疗横纹肌溶解症的 COVID-19 重型患者:一例报告。
J Formos Med Assoc. 2021 Sep;120(9):1777-1781. doi: 10.1016/j.jfma.2021.03.014. Epub 2021 Mar 24.